30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Applied Molecular Transport Inc. (AMTI)

Track

Stock chart
Ticker: AMTI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Hants Brandon
CFO
1 sale — total 10,054 USD
Sale 22 Nov 2023
Value US$731,961.27 | Price 432.94 | Shares 26,468
Sale 22 Nov 2023
Value US$3,714,937.74 | Price 79.85 | Shares 34,704
Sale 22 Nov 2023
Value US$18,116.13 | Price 0.16 | Shares 110,802
Sale 15 Nov 2023
Value US$14,525.79 | Price 0.16 | Shares 90,447
Sale 15 Nov 2023
Value US$8,053.45 | Price 0.16 | Shares 50,146
Sale 6 Oct 2023
Value US$30,377.60 | Price 0.16 | Shares 184,442
Sale 29 Sep 2023
Value US$17,045.09 | Price 0.16 | Shares 107,540
Sale 29 Sep 2023
Value US$30,742.66 | Price 0.16 | Shares 193,960
Sale 5 Sep 2023
Value US$465.84 | Price 0.21 | Shares 2,245
Sale 5 Sep 2023
Value US$148.98 | Price 0.21 | Shares 718
Sale 5 Sep 2023
Value US$260.00 | Price 0.21 | Shares 1,253
Sale 2 Jun 2023
Value US$480.67 | Price 0.24 | Shares 1,992
Sale 2 Jun 2023
Value US$134.40 | Price 0.24 | Shares 560
Sale 2 Jun 2023
Value US$396.29 | Price 0.24 | Shares 1,643
Sale 2 Jun 2023
Value US$114.58 | Price 0.24 | Shares 477
Sale 2 Jun 2023
Value US$128.85 | Price 0.24 | Shares 536
Sale 2 Jun 2023
Value US$794.27 | Price 0.24 | Shares 3,293
Sale 1 Mar 2023
Value US$269.88 | Price 0.50 | Shares 539
Sale 1 Mar 2023
Value US$252.00 | Price 0.50 | Shares 504
Sale 1 Mar 2023
Value US$467.00 | Price 0.50 | Shares 934
Sale 1 Mar 2023
Value US$901.00 | Price 0.50 | Shares 1,802
Sale 1 Mar 2023
Value US$241.05 | Price 0.50 | Shares 482
Sale 2 Dec 2022
Value US$4,088.04 | Price 1.05 | Shares 3,893
Planned sale 2 Dec 2022
Value US$0.00 | Price 0.00 | Shares 1,772
Sale 2 Dec 2022
Value US$438.94 | Price 1.05 | Shares 418
Planned sale 2 Dec 2022
Value US$2,057.15 | Price 1.05 | Shares 1,959
Sale 2 Dec 2022
Value US$4,440.87 | Price 1.05 | Shares 4,229
Planned sale 2 Dec 2022
Value US$3,662.75 | Price 1.05 | Shares 3,488
Buy 28 Nov 2022
Value US$49,975.00 | Price 1.00 | Shares 50,000
Buy 25 Nov 2022
Value US$99,660.00 | Price 1.00 | Shares 100,000
Planned sale 1 Sep 2022
Value US$655.99 | Price 1.42 | Shares 462
Sale 1 Sep 2022
Value US$636.07 | Price 1.42 | Shares 448
Sale 1 Sep 2022
Value US$590.68 | Price 1.42 | Shares 416
Sale 1 Sep 2022
Value US$664.70 | Price 1.42 | Shares 468
Planned sale 1 Sep 2022
Value US$2,447.18 | Price 1.42 | Shares 1,723
Planned sale 1 Sep 2022
Value US$713.91 | Price 1.42 | Shares 503
Planned sale 1 Sep 2022
Value US$573.60 | Price 1.42 | Shares 404
Sale 2 Jun 2022
Value US$6,590.06 | Price 3.04 | Shares 2,166
Sale 2 Jun 2022
Value US$3,413.68 | Price 3.04 | Shares 1,122
Sale 2 Jun 2022
Value US$6,681.33 | Price 3.04 | Shares 2,196
Sale 2 Jun 2022
Value US$7,916.58 | Price 3.04 | Shares 2,602
Sale 2 Jun 2022
Value US$1,192.66 | Price 3.04 | Shares 392
Sale 2 Jun 2022
Value US$5,150.95 | Price 3.04 | Shares 1,693
Sale 1 Jun 2022
Value US$5,244.28 | Price 2.97 | Shares 1,767
Sale 1 Jun 2022
Value US$2,715.63 | Price 2.97 | Shares 915
Sale 1 Jun 2022
Value US$5,318.48 | Price 2.97 | Shares 1,792
Sale 1 Jun 2022
Value US$6,300.85 | Price 2.97 | Shares 2,123
Sale 1 Jun 2022
Value US$946.76 | Price 2.97 | Shares 319
Sale 1 Jun 2022
Value US$4,101.64 | Price 2.97 | Shares 1,382
Buy 23 May 2022
Value US$109,210.00 | Price 3.26 | Shares 33,500
Buy 20 May 2022
Value US$101,640.00 | Price 3.08 | Shares 33,000
Buy 13 May 2022
Value US$124,123.62 | Price 4.17 | Shares 29,763
Buy 12 May 2022
Value US$125,634.40 | Price 3.88 | Shares 32,380
Buy 1 Mar 2022
Value US$290,929.92 | Price 6.34 | Shares 45,888
Buy 28 Feb 2022
Value US$26,769.12 | Price 6.51 | Shares 4,112
Buy 28 Jan 2022
Value US$23,640.00 | Price 7.88 | Shares 3,000
Buy 9 Dec 2021
Value US$52,463.60 | Price 14.99 | Shares 3,500
Buy 17 Nov 2021
Value US$159,684.15 | Price 22.38 | Shares 7,135
Buy 16 Nov 2021
Value US$90,298.40 | Price 22.57 | Shares 4,000
Planned sale 7 Jul 2021
Value US$2,148.16 | Price 43.84 | Shares 49
Planned sale 7 Jul 2021
Value US$34,136.00 | Price 42.67 | Shares 800
Planned sale 7 Jul 2021
Value US$279,408.51 | Price 42.01 | Shares 6,651
Buy 6 Apr 2021
Value US$1,050,000.00 | Price 42.00 | Shares 25,000
Buy 9 Jun 2020
Value US$3,080,000.00 | Price 14.00 | Shares 220,000
Buy 9 Jun 2020
Value US$35,000,000.00 | Price 14.00 | Shares 2,500,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-27 2023-11-22 S Sale
Hants Brandon

CFO

Officer
26,468 +44.5%
432.94
US$731,961 		26,468 +44.5% 432.94 US$731,961
2023-11-27 2023-11-22 S Sale
0.5
Mahmood Tahir Ph.D.
Non-Executive Director
34,704 +38.0%
79.85
US$3,714,938 		34,704 +38.0% 79.85 US$3,714,938
2023-11-24 2023-11-22 S Sale
Cross Shawn

CEO & Chair of the Board

Executive Director
91,111 -20.5%
390.15
US$954,674 		91,111 -20.5% 390.15 US$954,674
2023-11-16 2023-11-15 S Sale
Cross Shawn

CEO & Chair of the Board

Executive Director
90,447 -12.1%
0.16
US$14,526 		90,447 -12.1% 0.16 US$14,526
2023-11-16 2023-11-15 S Sale
Hants Brandon

CFO

Officer
50,146 -12.1%
0.16
US$8,053 		50,146 -12.1% 0.16 US$8,053
2023-10-10 2023-10-06 S Sale
0.5
Mahmood Tahir Ph.D.
Non-Executive Director
184,442 -19.3%
0.16
US$30,378 		184,442 -19.3% 0.16 US$30,378
2023-10-02 2023-09-29 S Sale
Hants Brandon

CFO

Officer
107,540 -20.5%
0.16
US$17,045 		107,540 -20.5% 0.16 US$17,045
2023-10-02 2023-09-29 S Sale
Cross Shawn

CEO & Chair of the Board

Executive Director
193,960 -20.5%
0.16
US$30,743 		193,960 -20.5% 0.16 US$30,743
2023-10-04 2023-09-05 S Sale
0.5
Mahmood Tahir Ph.D.
Non-Executive Director
2,245 -3.1%
0.21
US$466 		2,245 -3.1% 0.21 US$466
2023-10-04 2023-09-05 S Sale
Hants Brandon

CFO

Officer
718 -0.2%
0.21
US$149 		718 -0.2% 0.21 US$149
2023-10-04 2023-09-05 S Sale
Cross Shawn

CEO & Chair of the Board

Executive Director
1,253 -0.2%
0.21
US$260 		1,253 -0.2% 0.21 US$260
2023-10-04 2023-06-02 S Sale
0.5
Mahmood Tahir Ph.D.
Non-Executive Director
1,992 -2.7%
0.24
US$481 		1,992 -2.7% 0.24 US$481
2023-10-04 2023-06-02 S Sale
Hants Brandon

CFO

Officer
560 -0.1%
0.24
US$134 		560 -0.1% 0.24 US$134
2023-10-04 2023-06-02 S Sale
Hants Brandon

CFO

Officer
1,643 -0.4%
0.24
US$396 		1,643 -0.4% 0.24 US$396
2023-10-04 2023-06-02 S Sale
Cross Shawn

CEO & Chair of the Board

Executive Director
477 -0.1%
0.24
US$115 		477 -0.1% 0.24 US$115
2023-10-04 2023-06-02 S Sale
Cross Shawn

CEO & Chair of the Board

Executive Director
536 -0.1%
0.24
US$129 		536 -0.1% 0.24 US$129
2023-10-04 2023-06-02 S Sale
Cross Shawn

CEO & Chair of the Board

Executive Director
3,293 -0.4%
0.24
US$794 		3,293 -0.4% 0.24 US$794
2023-03-03 2023-03-01 S Sale
Kanwar Bittoo

Chief Medical Officer

Officer
539 -0.7%
0.50
US$270 		539 -0.7% 0.50 US$270
2023-03-03 2023-03-01 S Sale
Hants Brandon

CFO

Officer
504 -1.5%
0.50
US$252 		504 -1.5% 0.50 US$252
2023-03-03 2023-03-01 S Sale
Cross Shawn

President & COO

Officer
934 -1.5%
0.50
US$467 		934 -1.5% 0.50 US$467
2023-03-03 2023-03-01 S Sale
0.5
Mahmood Tahir Ph.D.

Chief Executive Officer

Executive Director
1,802 -2.4%
0.50
US$901 		1,802 -2.4% 0.50 US$901
2023-03-03 2023-03-01 S Sale
Rich Douglas A.

Chief Technical Officer

Officer
482 -1.0%
0.50
US$241 		482 -1.0% 0.50 US$241
2022-12-06 2022-12-02 S Sale
Cross Shawn

President & COO

Officer
3,893 -6.0%
1.05
US$4,088 		3,893 -6.0% 1.05 US$4,088
2022-12-06 2022-12-02 PlS Planned sale
0.5
Mahmood Tahir Ph.D.

Chief Executive Officer

Executive Director
1,772
0.00
US$0 		1,772 0.00 US$0
2022-12-06 2022-12-02 S Sale
0.5
Mrsny Randall Ph.D.
Non-Executive Director
418 -1.9%
1.05
US$439 		418 -1.9% 1.05 US$439
2022-12-06 2022-12-02 PlS Planned sale
Hants Brandon

CFO

Officer
1,959 -5.6%
1.05
US$2,057 		1,959 -5.6% 1.05 US$2,057
2022-12-06 2022-12-02 S Sale
Rich Douglas A.

Chief Technical Officer

Officer
4,229 -7.8%
1.05
US$4,441 		4,229 -7.8% 1.05 US$4,441
2022-12-06 2022-12-02 PlS Planned sale
Kanwar Bittoo

Chief Medical Officer

Officer
3,488 -4.3%
1.05
US$3,663 		3,488 -4.3% 1.05 US$3,663
2022-11-29 2022-11-28 B Purchase
1.5
VanDevender Aaron
Non-Executive Director
50,000 +30.7%
1.00
US$49,975 		50,000 +30.7% 1.00 US$49,975
2022-11-29 2022-11-25 B Purchase
1.5
VanDevender Aaron
Non-Executive Director
100,000 +159.6%
1.00
US$99,660 		100,000 +159.6% 1.00 US$99,660
2022-09-06 2022-09-01 PlS Planned sale
Hants Brandon

CFO

Officer
462 -1.3%
1.42
US$656 		462 -1.3% 1.42 US$656
2022-09-06 2022-09-01 S Sale
Rich Douglas A.

Chief Technical Officer

Officer
448 -0.8%
1.42
US$636 		448 -0.8% 1.42 US$636
2022-09-06 2022-09-01 S Sale
Cross Shawn

President & COO

Officer
416 -0.6%
1.42
US$591 		416 -0.6% 1.42 US$591
2022-09-06 2022-09-01 S Sale
Cross Shawn

President & COO

Officer
468 -0.7%
1.42
US$665 		468 -0.7% 1.42 US$665
2022-09-06 2022-09-01 PlS Planned sale
0.5
Mahmood Tahir Ph.D.

Chief Executive Officer

Executive Director
1,723 -2.3%
1.42
US$2,447 		1,723 -2.3% 1.42 US$2,447
2022-09-06 2022-09-01 PlS Planned sale
Kanwar Bittoo

Chief Medical Officer

Officer
503 -0.6%
1.42
US$714 		503 -0.6% 1.42 US$714
2022-09-06 2022-09-01 PlS Planned sale
0.5
Mrsny Randall Ph.D.
Non-Executive Director
404 -1.8%
1.42
US$574 		404 -1.8% 1.42 US$574
2022-06-03 2022-06-02 S Sale
Cross Shawn

President & COO

Officer
2,166 -3.2%
3.04
US$6,590 		2,166 -3.2% 3.04 US$6,590
2022-06-03 2022-06-02 S Sale
Hants Brandon

CFO

Officer
1,122 -3.3%
3.04
US$3,414 		1,122 -3.3% 3.04 US$3,414
2022-06-03 2022-06-02 S Sale
Kanwar Bittoo

Chief Medical Officer

Officer
2,196 -2.7%
3.04
US$6,681 		2,196 -2.7% 3.04 US$6,681
2022-06-03 2022-06-02 S Sale
Rich Douglas A.

Chief Technical Officer

Officer
2,602 -4.6%
3.04
US$7,917 		2,602 -4.6% 3.04 US$7,917
2022-06-03 2022-06-02 S Sale
0.5
Mrsny Randall Ph.D.
Non-Executive Director
392 -1.9%
3.04
US$1,193 		392 -1.9% 3.04 US$1,193
2022-06-03 2022-06-02 S Sale
0.5
Mahmood Tahir Ph.D.

Chief Executive Officer

Executive Director
1,693 -2.2%
3.04
US$5,151 		1,693 -2.2% 3.04 US$5,151
2022-06-03 2022-06-01 S Sale
Cross Shawn

President & COO

Officer
1,767 -2.5%
2.97
US$5,244 		1,767 -2.5% 2.97 US$5,244
2022-06-03 2022-06-01 S Sale
Hants Brandon

CFO

Officer
915 -2.6%
2.97
US$2,716 		915 -2.6% 2.97 US$2,716
2022-06-03 2022-06-01 S Sale
Kanwar Bittoo

Chief Medical Officer

Officer
1,792 -2.1%
2.97
US$5,318 		1,792 -2.1% 2.97 US$5,318
2022-06-03 2022-06-01 S Sale
Rich Douglas A.

Chief Technical Officer

Officer
2,123 -3.6%
2.97
US$6,301 		2,123 -3.6% 2.97 US$6,301
2022-06-03 2022-06-01 S Sale
0.5
Mrsny Randall Ph.D.
Non-Executive Director
319 -1.5%
2.97
US$947 		319 -1.5% 2.97 US$947
2022-06-03 2022-06-01 S Sale
0.5
Mahmood Tahir Ph.D.

Chief Executive Officer

Executive Director
1,382 -1.8%
2.97
US$4,102 		1,382 -1.8% 2.97 US$4,102
2022-05-23 2022-05-23 B Purchase
3.7
Lamond David
Non-Executive Director
33,500 +3.2%
3.26
US$109,210 		33,500 +3.2% 3.26 US$109,210
2022-05-23 2022-05-20 B Purchase
3.7
Lamond David
Non-Executive Director
33,000 +3.3%
3.08
US$101,640 		33,000 +3.3% 3.08 US$101,640
2022-05-16 2022-05-13 B Purchase
1.9
EPIQ Capital Group, LLC
29,763 +0.4%
4.17
US$124,124 		29,763 +0.4% 4.17 US$124,124
2022-05-16 2022-05-12 B Purchase
1.9
EPIQ Capital Group, LLC
32,380 +0.4%
3.88
US$125,634 		32,380 +0.4% 3.88 US$125,634
2022-03-02 2022-03-01 B Purchase
1.5
VanDevender Aaron
Non-Executive Director
45,888 +273.6%
6.34
US$290,930 		45,888 +273.6% 6.34 US$290,930
2022-03-02 2022-02-28 B Purchase
1.5
VanDevender Aaron
Non-Executive Director
4,112 +32.5%
6.51
US$26,769 		4,112 +32.5% 6.51 US$26,769
2022-01-31 2022-01-28 B Purchase
0.5
Mahmood Tahir Ph.D.

Chief Executive Officer

Executive Director
3,000 +inf%
7.88
US$23,640 		3,000 +inf% 7.88 US$23,640
2021-12-10 2021-12-09 B Purchase
0.5
Mrsny Randall Ph.D.

Chief Scientific Officer

Executive Director
3,500 +inf%
14.99
US$52,464 		3,500 +inf% 14.99 US$52,464
2021-11-18 2021-11-17 B Purchase
1.9
EPIQ Capital Group, LLC
7,135 +0.1%
22.38
US$159,684 		7,135 +0.1% 22.38 US$159,684
2021-11-18 2021-11-16 B Purchase
1.9
EPIQ Capital Group, LLC
4,000 +0.0%
22.57
US$90,298 		4,000 +0.0% 22.57 US$90,298
2021-07-08 2021-07-07 PlS Planned sale
Kanwar Bittoo

Chief Medical Officer

Officer
49 -100.0%
43.84
US$2,148 		49 -100.0% 43.84 US$2,148
2021-07-08 2021-07-07 PlS Planned sale
Kanwar Bittoo

Chief Medical Officer

Officer
800 -94.2%
42.67
US$34,136 		800 -94.2% 42.67 US$34,136
2021-07-08 2021-07-07 PlS Planned sale
Kanwar Bittoo

Chief Medical Officer

Officer
6,651 -88.7%
42.01
US$279,409 		6,651 -88.7% 42.01 US$279,409
2021-04-07 2021-04-06 B Purchase
3.7
Lamond David
Non-Executive Director
25,000 +2.5%
42.00
US$1,050,000 		25,000 +2.5% 42.00 US$1,050,000
2020-06-11 2020-06-09 B Purchase
1.9
EPIQ Capital Group, LLC

Managing Member of 10% owner
220,000 +2.7%
14.00
US$3,080,000 		220,000 +2.7% 14.00 US$3,080,000
2020-06-11 2020-06-09 B Purchase
1.9
EPIQ Capital Group, LLC

Managing Member of 10% owner
2,500,000 +45.1%
14.00
US$35,000,000 		2,500,000 +45.1% 14.00 US$35,000,000
Explore more

More insider trading research around Applied Molecular Transport Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America